{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:31:53Z","timestamp":1784871113780,"version":"3.55.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,29]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Congenital factor VII deficiency is the most common among rare bleeding disorders, characterized by spontaneous or traumatic bleeding. The clinical manifestation is heterogeneous, ranging from asymptomatic phenotype to life-threatening hemorrhages. Intracranial hemorrhage is a common complication of brain tumor neurosurgery, which significantly challenges the perioperative management of patients with hemostatic defects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>This report presented a 55-year-old man with congenital factor VII deficiency, who had no history of hemorrhage or family history. He underwent a craniotomy for the treatment of papillary craniopharyngioma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was diagnosed as papillary craniopharyngioma, factor VII deficiency, and atrial fibrillation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>To prevent bleeding, a total of 8 doses of recombinant activated factor VII and 1 dose of fresh frozen plasma were administered as the perioperative replacement therapy. This scheme was guided by a pharmacodynamic evaluation, laboratory tests, and imaging examinations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>No excessive surgical bleeding was observed during the 22-day treatment. The patient was found to have compound heterozygous mutations, Ala304Thr (c.910G &gt; A) and IVS5-2A &gt; G (c.572-2A &gt; G), in the F7 gene.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This is the first reported case in which surgical hemorrhage secondary to brain tumor resection was successfully controlled in the presence of congenital factor VII deficiency. Perioperative coagulation state, hemostasis, and thrombosis events should be closely observed, and the interval and dosage of recombinant factor VIIa should be adjusted accordingly.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036694","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:00:55Z","timestamp":1704816055000},"page":"e36694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-1960","authenticated-orcid":false,"given":"Chaoyu","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjia","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningneng","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3074-3246","authenticated-orcid":false,"given":"Wuning","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-4339","authenticated-orcid":false,"given":"Faquan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology.","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders.","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3324\/haematol.2020.248542","article-title":"Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.","volume":"106","author":"Bernardi","year":"2021","journal-title":"Haematologica"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","article-title":"Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.","volume":"15","author":"Herrmann","year":"2009","journal-title":"Haemophilia"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jcm6040038","article-title":"Factor VII deficiency: clinical phenotype, genotype and therapy.","volume":"6","author":"Napolitano","year":"2017","journal-title":"J Clin Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2516.2008.01844.x","article-title":"Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.","volume":"14","author":"Lapecorella","year":"2008","journal-title":"Haemophilia"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1160\/TH04-10-0650","article-title":"Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.","volume":"93","author":"Mariani","year":"2005","journal-title":"Thromb Haemost"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/j.1365-2516.2012.02751.x","article-title":"Invasive procedures and minor surgery in factor VII deficiency.","volume":"18","author":"Mariani","year":"2012","journal-title":"Haemophilia"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjh.15055","article-title":"Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry.","volume":"180","author":"Di Minno","year":"2018","journal-title":"Br J Haematol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2019.07.014","article-title":"The use of prophylaxis in the treatment of rare bleeding disorders.","volume":"196","author":"Shapiro","year":"2020","journal-title":"Thromb Res"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/ehm.11.76","article-title":"Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report.","volume":"5","author":"Sheth","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.2010.08287.x","article-title":"Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.","volume":"152","author":"Mariani","year":"2011","journal-title":"Br J Haematol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1538-7836.2011.04291.x","article-title":"A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients.","volume":"9","author":"Benlakhal","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/ejh.13941","article-title":"Management of rare inherited bleeding disorders: proposals of the French Reference Centre on haemophilia and rare coagulation disorders.","volume":"110","author":"Trossaert","year":"2023","journal-title":"Eur J Haematol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia.","volume":"133","author":"Menegatti","year":"2019","journal-title":"Blood"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1111\/hae.12164","article-title":"Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report.","volume":"19","author":"Frattini","year":"2013","journal-title":"Haemophilia"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MBC.0b013e328352e8e2","article-title":"Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.","volume":"23","author":"Livnat","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0218492317702784","article-title":"Factor VII deficiency: do all need replacement for cardiac surgery?","volume":"27","author":"Khazi","year":"2019","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2516.2012.02921.x","article-title":"Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.","volume":"19","author":"Windyga","year":"2013","journal-title":"Haemophilia"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/hae.12312","article-title":"Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report.","volume":"20","author":"Shirasawa","year":"2014","journal-title":"Haemophilia"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/bja\/aep293","article-title":"Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.","volume":"103","author":"Liu","year":"2009","journal-title":"Br J Anaesth"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"106892","DOI":"10.1016\/j.ijscr.2022.106892","article-title":"Perioperative management for patient with congenital factor VII deficiency who underwent laparoscopic cholecystectomy: case report.","volume":"92","author":"Yoshimura","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01390530","article-title":"Successful excision of hemorrhagic cavernous angioma in a patient with severe factor VII deficiency: perioperative treatment with factor VII concentrate.","volume":"20","author":"Brunori","year":"1997","journal-title":"Neurosurg Rev"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11748-014-0455-1","article-title":"Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.","volume":"64","author":"Miyata","year":"2016","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00701-009-0409-z","article-title":"Hemostatic and hemorrhagic problems in neurosurgical patients.","volume":"151","author":"Gerlach","year":"2009","journal-title":"Acta Neurochir (Wien)"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.thromres.2020.09.005","article-title":"Preoperative and intraoperative predictors of deep venous thrombosis in adult patients undergoing craniotomy for brain tumors: a Chinese single-center, retrospective study.","volume":"196","author":"Shi","year":"2020","journal-title":"Thromb Res"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1111\/hae.12782","article-title":"Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery.","volume":"21","author":"Napolitano","year":"2015","journal-title":"Haemophilia"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12959-023-00494-3","article-title":"A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency.","volume":"21","author":"Li","year":"2023","journal-title":"Thromb J"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"e33437","DOI":"10.1097\/MD.0000000000033437","article-title":"Paradoxical massive pulmonary thromboembolism in a postpartum woman with factor VII deficiency with bleeding tendency: a case report.","volume":"102","author":"Kang","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11239-009-0435-y","article-title":"Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency critical review of the literature.","volume":"30","author":"Girolami","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/JBM.S219573","article-title":"Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).","volume":"10","author":"Rajpurkar","year":"2019","journal-title":"J Blood Med"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"845273","DOI":"10.3389\/fsurg.2022.845273","article-title":"Clinical features of craniopharyngioma with tumoral hemorrhage: a retrospective case-controlled study.","volume":"9","author":"Chen","year":"2022","journal-title":"Frontiers in Surgery"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.22937","article-title":"Risk factors and management of deep venous thrombosis in children following post-surgical hypopituitarism in craniopharyngioma.","volume":"57","author":"Chandrakasan","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2516.2006.01180.x","article-title":"Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.","volume":"12","author":"Mariani","year":"2006","journal-title":"Haemophilia"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1160\/TH12-07-0476","article-title":"Replacement therapy for bleeding episodes in factor VII deficiency: a prospective evaluation.","volume":"109","author":"Mariani","year":"2013","journal-title":"Thromb Haemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:24:10Z","timestamp":1746318250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":36,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036694","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}